|
MDXG
|
MiMedx Group, Inc
|
US
|
NASDAQ
|
|
MESO
|
Mesoblast Limited
|
US
|
NASDAQ
|
|
MGNX
|
MacroGenics, Inc.
|
US
|
NASDAQ
|
|
MOLN
|
Molecular Partners AG
|
US
|
NASDAQ
|
|
MRK
|
Merck & Company, Inc.
|
US
|
NYSE
|
|
MRNA
|
Moderna, Inc.
|
US
|
NASDAQ
|
|
MRVI
|
Maravai LifeSciences Holdings, Inc.
|
US
|
NASDAQ
|
|
MTCR
|
Metacrine, Inc.
|
US
|
NASDAQ
|
|
MXCT
|
MaxCyte, Inc.
|
US
|
NASDAQ
|
|
NGM
|
NGM Biopharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
NHWK
|
NightHawk Biosciences, Inc.
|
US
|
AMEX
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NRXP
|
NeuroRx, Inc.
|
US
|
NASDAQ
|
|
NVCT
|
Nuvectis Pharma, Inc.
|
US
|
NASDAQ
|
|
NVO
|
Novo Nordisk A/S
|
US
|
NYSE
|
|
OGN
|
Organon & Co.
|
US
|
NYSE
|
|
OMIC
|
Singular Genomics Systems, Inc.
|
US
|
NASDAQ
|
|
ONCY
|
Oncolytics Biotech Inc.
|
US
|
NASDAQ
|
|
OTLK
|
Outlook Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PACB
|
Pacific Biosciences of California, Inc.
|
US
|
NASDAQ
|